The study investigated r ezatapopt (PC14586), a first-in-class small molecule designed to selectively bind and reactivate the ...
LG Chem has doubled down on developing an innovative cancer treatment by zeroing in on undruggable targets through a ...
Korean pharmaceutical and biotech corporations will unveil next-generation anticancer research at the American Association for Cancer Research (AACR), to be held in San Diego from the 17th to the 22nd ...
A therapy that targets a mutation in a critical tumor suppressor gene exhibited “impressive” activity in a cohort of heavily ...
Discover how TP53 mutations in adult leukaemia impact treatment outcomes and potential strategies for improved patient care.
FMC-220 was discovered using the Frontier (TM) Platform, integrating chemoproteomics and AI for covalent-based drug discovery. FMC-220 is the second potential first-in-class program to advance from ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
In 1977, Richard Peto, a British epidemiologist, theorized that large-bodied animals like elephants are more likely to ...
Fi Novelist Who Disappeared for Decades In “What We Are Seeking,” the cult author Cameron Reed returns to show us a strange, ...
Born out of pioneering research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute, and anchored around a proprietary platform that has seen 20 years of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results